Ista Pharmaceuticals (ISTA) Inactive 10-Q2010 Q1 Quarterly report

Filed: 30 Apr 10, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: add, adequate, Alliance, AmeriSource, assume, assuming, awaiting, bad, Bausch, Bergen, Biozyme, bulk, Cardinal, category, Central, claim, Complaint, concentration, Court, damaged, declaratory, destroyed, enacted, equipment, exceed, exceeded, exclusive, gain, HBOC, Health, healthcare, highly, indirect, individual, individually, intellectual, key, larger, legislation, lengthening, likelihood, Lomb, lot, McKesson, Medicaid, negatively, onsite, outcome, partnering, party, patent, penetration, personal, produce, promptly, property, provision, Puerto, pull, purified, repayment, resolved, Rico, roll, Senju, site, stage, supplier, Thursday, trade, treasury, treat, trending, typically, unallocated, undistributed, unfavorable, XiDay

Removed: adjustment, affiliate, AG, allocation, amortized, analyze, began, beginning, breakeven, carried, classification, classified, collaborative, compete, component, conservative, consistent, decreased, Deerfield, designated, developed, devoted, earned, embedded, entity, execution, existence, expand, extinguished, filing, finalized, focused, force, fund, Hedging, highest, Incentive, indexed, inherently, initially, June, lead, manner, mark, month, nonconvertible, par, partial, partially, permitted, principle, QD, qualified, quick, ranging, ratified, ratio, reclassification, reclassified, reclassify, removed, represented, residual, retrospective, retrospectively, routine, schedule, separately, settled, settlement, study, UBS, uncertain, varying

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

ISTA similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION

I, Lauren P. Silvernail, hereby certify pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, that the Quarterly Report of ISTA Pharmaceuticals, Inc. on Form 10-Q for the quarterly period ended March 31, 2010 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q for the period ended March 31, 2010 fairly presents in all material respects the financial condition and results of operations of ISTA Pharmaceuticals, Inc.



Date: April 30, 2010								/s/ Lauren P. Silvernail
								Lauren P. Silvernail Chief Financial Officer and Vice President, Corporate Development

This certification accompanies the Quarterly Report pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934.